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 ABSTRACT : 
Microcytic hypochromic anemia  is  the most common type of anemia in childhood. The 
differential diagnosis includes  Iron deficiency anemia, anemia of chronic disease, thalassemia 
and sideroblastic anemia .Iron deficiency anemia is a major global health problem as it causes 
anemia  as  well as impaired coginitive and motor development along with behavioural 
abnormalities.  In developing countries 39 %  children below 5 years and 48 % children between 
5 -14 years suffer from anemia.  Children present in the hospital  either with symptoms and signs 
of anemia or with manifestations of other diseases during which screening reveals anemia. In the 
current study, 50 children in the age group between 6 months to 12 years, with  microcytic 
hypochromic anemia, identified in the peripheral smear report as well as complete blood 
hemogram, were randomly selected and their red cell indices were correlated with serum iron 
profile assuming them to be sensitive and specific for the differential diagnosis. The predominant 
age group involved was between 6 months to 5 years. Male to female ratio was 1.7:1. Mean age 
was 5.6 years.  Out of 50 cases, 41(82%)  were IDA cases, 8(16%) were anemia of chronic 
disease cases and only 1 (2%) was thalassemia major. In the differential diagnosis of microcytic 
hypochromic anemia, the correlative study revealed red cell distribution width (RDW) to be most 
sensitive in the diagnosis of iron deficiency anemia. There was also a statistically significant 
correlation between the  RDW  and serum iron profile. Of the various red cell formulas,  Sirdah, 
RBC count, England &Fraser together were 100 % sensitive followed by RDWI  and Mentzer’s 
index, in the diagnosis of IDA. For the ACD cases, the cost effective   approach  is   to correlate 
the clinical features and  perform a CRP level to confirm the underlying chronic disease. After 
the treatment of underlying disease if the anemia is not corrected, then serum iron can be 
performed. In our study, all ACD cases had elevated CRP levels along with the clinical features 
of underlying diseases. Also the RDW was normal in 6 out of 8 cases of ACD. For thalassemia 
major, owing to life long transfusion necessity, costly investigations like Hb electrophoresis  are  
needed for confirmation. 
 
 
KEY WORDS: 
Microcytic  Hypochromic anemia, Iron deficiency anemia, Anemia of chronic disease, 
Thalassemia major, Red Cell Distribution Width, Red Cell Formulas, Serum Iron Profile. 
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INTRODUCTION 
Microcytic hypochromic anemias in children are most commonly due to iron 
deficiency anemia and less commonly due to thalassemias, sideroblastic anemias, lead 
poisoning and anemia of chronic disease. Global anemia prevalence estimates 47 
percent of children younger than 5 years have anemia(15). Of the various countries 
India has the highest prevalence of anemia .80 % of children under 2 years of age are 
anemic(2).In children aged 6-59 months in India,7 in 10  are anemic. About 10% of 
world’s children are born with hemoglobinopathies every year.(3) 
The cost factor involved and the technical short comings in performing iron 
profile studies especially in developing countries like   India   makes it necessary for a 
study which correlates the sensitivity of various red cell indices obtained from the 
automated cell counters, the peripheral smear findings, the red cell formulas with  the 
iron profile of   the  anemic children  admitted in the Government Raja  Mirasudar 
Hospital, Thanjavur attached to Thanjavur Medical College. 
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                                  MATERIAL AND METHODS 
The present study was conducted on 50 randomly selected children admitted 
in the pediatric department, Raja Mirasudar hospital, Thanjavur. After informed 
consent, samples were collected in 2 ml EDTA   tubes and 3 ml in another sterile 
container. The EDTA (k2) anti coagulated   sample was used to estimate complete 
hemogram with the sysmex K-1( 3 part analyser), peripheral smear and  reticulocyte 
count. 
Following red cell   indices were obtained from the hematology analyser. 
Mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean 
corpuscular hemoglobin concentration (MCHC)  and red cell distribution 
width(RDW). Peripheral smear was done to subtype the anemia. Reticulocyte count 
was done to assess the erythropoietic response of bone marrow as well as to rule out 
hemolytic anemia. In cases of thalassemia, HbF was done to confirm the diagnosis by 
hemoglobin electrophoresis. From the sterile container, serum was separated to assess 
iron profile which includes serum iron, serum ferritin, percent saturation of transferrin 
and total iron binding capacity (TIBC) levels. 
              In the peripheral smear, the grade of microcytosis and percentage of smears 
showing pencil cells were estimated. 
             With the red cell indices, the following red cell formulas(4) were calculated for 
all patients.  
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Index Formula Thalassemia trait. Iron deficiency anemia 
England &Fraser MCV-RBC-(5XHB) -8.4 < 0 (neg) >0 (pos) 
Mentzer’s  MCV/RBC Less than  13 Greater than 13 
Srivastava MCH/RBC <3.8 >3.8 
Shine and lal (MCV)(MCV)X MCH 
/100 
<1530 >1530 
Green and king  MCVXMCVXRDW/Hb 
x 100 
<72 >72 
Ricerca RDW/RBC <3.3 >3.3 
RDWI MCV x RDW/RBC <220 >220 
SIRDAH MCV-RBC-(3X Hb)   
 
All the data compiled and tabulated for correlation. The parameters taken for 
correlation were: 
1.Red cell indices and iron profile values. 
2.Red cell formulas and iron profile values. 
Inclusion criteria: 
1.Children from age 6 months to 12 years. 
2.Anemic children as per WHO cut off values. 
3.Microcytic hypochromia as per peripheral smear and red cell indices. 
Exclusion criteria: 
1.New born children and age less than 6 months. 
2.Children with macrocytic  and normocytic anemias. 
3.Smears with markedly elevated reticulocyte counts. 
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AIMS AND OBJECTIVES 
1.To find out the proportion of various causes of microcytic hypochromic anemia. 
2.To calculate the sensitivity and specificity values of  red cell distribution 
width(RDW) and red cell formulas. 
3.To correlate these values with iron profile values assuming them to be most 
sensitive. 
4.To find out which red cell index identifies the cause of anemia without iron 
values(red cell index with highest sensitivity) especially red cell distribution width. 
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REVIEW OF LITERATURE 
Worldwide 1.62 billion people are affected by anemia.Children less than five 
years show the highest prevalence. 48% of children between 5-14 years suffer from 
anemia.(WHO Data base 2005). In the  World health organisation report it was 
estimated that 12% of children less than five years age were anemic  in the developed 
countries and 51% of children in the same age group in the developing world are 
anemic.(9)(43) 
Anemia is defined as hemoglobin or hematocrit lower than  age & sex  
adjusted range for healthy children.(1)  Functionally anemia is  defined as inadequate 
RBC mass to carry oxygen to the tissues.(6) Depending on age, gender and race 
normal values show variation. In anemia, the metabolic needs of the body are poorly 
met with. By itself it is not a disease.Pediatric reference ranges are helpful because 
analysers cannot detect normal age related variations in Hb,HCT,MCV etc. 
throughout childhood.  Comparison with age specific values is necessary for all 
abnormal values. Any value less than 2 SD is regarded as abnormal. 
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Table 1(1): 
Normal hemoglobin,hematocrit and mean corpuscular volume values in various 
ages. 
 HEMOGLOBIN(g/dL) HEMATOCRIT(%) MCV(μm3) 
Age(years) Mean value Lower 
limit 
Mean Lower 
limit 
Mean 
value 
Lower 
limit 
0.5-1.9 12.5 11 37 33 77 70 
2-4 12.5 11 38 34 79 73 
5-7 13 11.5 39 35 81 75 
8-11 13.5 12.0 40 36 83 76 
12-14 
Female 
male 
 
13.5 
14.0 
 
12.0 
12.5 
 
41 
43 
 
36 
37 
 
85 
84 
 
78 
77 
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Table 2:(23) 
Hemoglobin concentration thresold used to define anemia as per WHO guidelines: 
Age or Gender Hb thresold level(g/l) HCT 
Children  
(6months to 5 years) 
110 <33 
Children 
(5 years to 12 years) 
115 <34 
Children 
(12 years to 15 years) 
120 <36 
 
WHO reports state when the anemia prevalence level  is greater than 40, it becomes a 
severe public health problem. When the level is reduced to less than 4.9, it ceases to 
be a health problem.The corresponding mild and moderated levels of prevalence are 5 
to 19.9(mild) and 20 to 39.9(moderate). 
ERYTHROPOIESIS: 
Erythropoiesis is the stepwise, programmed and regulated process during 
which the  precursors called erythroblasts , otherwise called normoblasts (with normal 
morphology) undergo changes in the cytoplasm and nucleus resulting in decrease in 
the size. Gradually during the process of differentiation, the proliferative capacity 
decreases with hemoglobin becoming the predominant cytoplasmic protein. 
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ERYTHROID SERIES: 
1.Proerythroblast: 
This large cell measures 14 -20 micro metres in diameter. Being the least 
mature of the series, the cell membrane is round with the characteristic feature seen in 
the cytoplasm. The cytoplasm is  basophilic compared to the myeloblast. Conspicuous 
round nucleoli are seen occcupying most of the cytoplasm.They are capable of rapid 
division. 
2. Basophil erythroblast: 
This round cell with a diameter 12 -16 µm has a more basophilic cytoplasm 
than it’s precursor cell. It is also capable of rapid proliferation. The nucleus is larger 
and coarser with basophilic chromatin. 
3.Polychromatic erythroblast: 
The diameter is 12 – 14 µm. The characteristic feature is the polychromatic 
cytoplasm which is due to mixture of acidophilic hemoglobin and basophilic 
ribonucleic acid(RNA). Proliferation ceases after this stage. Nucleus becomes more 
coarser. This cell is also called intermediate eythroblast because this stage occupies an 
intermediate position between the previous stages  and the later stages with the 
predominance of hemoglobin in the cytoplasm. 
4.Orthochromatic erythroblasts: 
In this final stage of maturation, the nucleus becomes small and pyknotic with 
a blue black appearance. But the cytoplasm is predominantly acidophilic due to 
hemoglobin content of the cytoplasm. 
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5.Reticulocyte: 
When the nucleus is extricated from the cytoplasm, the orthochromatic 
normoblast becomes a reticulocyte. As the reticulocytes have greater diameter, when 
their numbers increases, the mean corpuscular volume also increases. As the 
reticulocytes lose their mitochondria and ribosomes, basophilia decreases to become a 
mature erythrocyte. 
CLASSIFICATION: (1,6) 
Anemia is classified on the basis of functional disturbances into  
1.Disorders of effective red cell production. 
2.Disorders of rapid erythrocyte destruction or red cell loss. 
Anemia is classified morphologically on the basis of mean corpuscular volume into: 
1.Microcytic hypochromic anemias. 
2. Normocytic normochromic anemias. 
3.Macrocytic Normochromic anemias. 
Majority of the  conditions that  cause anemia also cause definable changes in mean 
corpuscular volume and can be grouped with this parameter.Anemia in children is 
caused by diseases that result in microcytic RBC’S.(2) 
HEMOGLOBIN OVERVIEW:(1,2) 
Microcytic anemia is caused by derangements in heme metabolism or globin 
synthesis. Hemoglobin is made up of  heme ring with iron and  4 globin chains. 
Dominant hemoglobin in utero is HbF with 2 alpha and 2 gamma globin 
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chains.HbA,adult hemoglobin  made of alpha and beta chains and HbA 2 with alpha 
and delta chains are dominant during intra uterine life. At  birth 80 % hemoglobin is 
HbF and HbA is 20%. By 6 months of life HbF is gradually replaced by HbA.The 
concentration of hemoglobin at birth is 14g/dl which becomes 11g/dl by 1 
year(physiological anemia of infancy).MCV at birth is 100 to 130fml.It decreases  
to70 to 85 fl  by 1 year of age. 
EVALUATION OF ANEMIA:(1,2) 
It is important that laboratory tests must be interpreted in the context of history 
and clinical examination. Only minimum  and important labortant tests need to be 
ordered. 
Initial  laboratory tests are hemoglobin estimation and hematocrit 
determination. Following which a peripheral smear and reticulocyte count is done. 
Others like platelet count and white cell count is sometimes needed. 
Special investigations like measurment of erythrocyte porphyrin, serum 
ferritin,supravital staining,hemoglobin electrophoresis and finally a bone marrow 
examination is needed when indicated. 
 Evaluation of basic hematology laboratory data(6): 
To identify the cause of anemia the details obtained from the history and 
clinical examination must be correlated with the lab tests.Some useful questions to be 
asked are: 
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Is the anemia associated with other hematologic abnormalities? 
If the answer is yes, then a bone marrow examination is performed to rule out 
leukemia, aplastic anemia, myelodysplasia and other marrow failure syndromes. 
If the answer is no, then the next question to be asked is  
Is the reticulocyte response to anemia is appropriate? 
The reticulocyte count gives a clue if the bone marrow is adequately 
responsive or not and whether the RBC’s are destroyed in the circulation or blood 
loss. 
Traditionally reticulocyte count is measured by microscopic examination of a 
smear  prepared from fresh blood stained with a supravital stain like new methylene 
blue.In the children  the normal reticulocyte count is up to 5%  in contrary to 
adults(0.5 to2%). The reticulocyte count needs to be corrected for the degree of 
anemia. 
1.Reticulocyte count= % reticulocytes in RBC population. 
2.Corrected reticulocyte count= % reticulocytes x (patient’s hematocrit/45) 
3. Absolute reticulocyte count= % reticulocytes x RBC count/L3. normal values are 
from 25 to 75 x109/ L. values less than 100 indicate inappropriately low erythropoietic 
response to anemia. 
If the answer to above question is yes then evidence of hemolysis such as 
increased bilirubin, increased LDH,decreased haptoglobin and hemosiderinuria must 
be sought. If the answer is no,then the red cell indices must be checked. If the MCV is 
less than 80 fml, microcytic anemia must be considered and evaluated. 
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APPROACH TO MICROCYTIC HYPOCHROMIC ANEMIAS:(DeGruchy’s) (45) 
                                        Microcytic hypochromic RBC 
                                                 Decreased MCV 
                                                 Decreased MCH 
 
 
                                                      Haemoglobin 
 
 
                       Decreased                                    Near normal /  
                                                                                                              Mildly decreased 
 
                   Reticulocyte count 
 
                         Decreased                       Increased    NormalRDW 
                Increased RBC count 
 
                  Serum iron studies      Smear shows 
                   abnormal RBC 
                  morphology / nRBCs            Consider
                                 thalassaemia trait 
 
Decreased serum iron      Decreased serum iron            Increased serum iron 
Increased TIBC             Normal / decreased TIBC      Normal TIBC 
Decreased Ferritin           Normal / increased ferritin    Increased Ferritin     
                        
         Consider 
               Homozygous 
              Thalassaemia/ 
             Haemoglobinopathy              Hb    
                 electrophoresis/ 
  HPLC for  
confirmation    
   IDA               Consider                     Consider 
                ACD                    sideroblastic 
                                    Anaemia 
 
    Review history for 
    underlying inflammatory             Bone marrow 
    disorder / acute phase  examination 
    response    with iron stain 
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Key history points:(1,6): 
Age:  
In infants aged  6 months to 5 years iron deficiency is more common. Severe β 
thalassemia is  diagnosed by age 6 months to 2 years.other thalassemias are usually 
diagnosed by 3 years. 
Gender: 
No gender difference is observed.. 
Race:  
In blacks Hemoglobin  S and C is seen more commonly while in whites Beta 
thalassemia is more common. 
Ethnicity:  
Thalassemias are encountered  commonly in patients of mediterranean origin 
and south east asia. 
Diet: 
Enquiry regarding intake of iron, vitamin B12 and folic acid containing foods 
must be noted.Pica if present may point to iron deficiency.Geo or pagopahgia refers to 
craving for clay or ice.Intake of cow’s milk and it’s volume  is important. 
Blood loss: (25) 
In older children blood loss is a possible cause. Occult bleeding may lead to 
chronic iron deficiency. Bleeding may be secondary to inflammatory colitis,peptic 
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ulcer, meckel’s diverticulum etc. In developing countries hook worm infestation is an 
important cause. 
Family history: 
Anemia in other members of the family must be enquired as some causes of 
microcytic anemias are inherited(2) 
AUTOMATED CELL  COUNTING (22): 
Owing to the greater precision, reproducibility and capacity for completing a 
large number of measurements quickly,automated cell counting  is preferred in the 
modern days. More over they are efficient,cost effective,lack inter observer variability 
and size distribution errors. Many  variables can be estimated which is not possible 
manually. Automation is employed in several fields in hematology for 
1.Cell counts( automated hematology analysers) 
2.Diagnosis of  hemoglobinopathies( high performance liquid chromatography) 
3.Immunophenotyping and diagnosis of leukemia and lymphomas( flow cytometry) 
4.Coagulation(coagulometers). 
Automated hematology analysers: 
There are 2 types of hematology analysers: 
1.Semiautomated analysers: some manual steps need to be carried out such as dilution 
of blood.only small number of variables can be evaluated. 
2.Fully automated analysers: no sample handling is required. Greater number of 
variables can be evaluated. 
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Components of cell counters: 
1.Hydraulics: aspirating unit,dispensers,diluters,mixing chambers,aperture baths and 
hemoglobinometer. 
2.Pneumatics: vacuums and pressures for operative valves. 
3. Electrical systems: analysers and computing circuits. 
Principles of analysers: 
Electronic impedance: 
In 1956,WALLACE COULTER introduced this principle of electronic 
impedance. This is based on observation that blood cells conduct electricity poorly.  
Two chambers filled with buffered electrolyte solution are separated by a small 
aperture and constant DC is applied. When a cell passes through the aperture it 
displaces a volume of diluent and increases the resistance thus producing a voltage 
pulse which is then displayed on the oscilloscope. 
Optical light scatter: 
The cells are made to  pass in a single stream before a light source. A photo 
diode detects the scattered light and converts it to electrical signals. These signals are 
analysed and presented graphically. 
Optical light scatter principle is used in 5 part differential count of WBC’S  
while impedance technology gives 3 part differential. 
 
 
26 
 
SYSMEX KX-21 HAEMATOLOGY ANALYSER: 
The Sysmex  KX-21 is   multi-parameter automatic blood cell counter. It is 
meant for in vitro diagnostic use in clinical laboratories. 
The KX-21 can process approximately 60 samples an hour and displays on the 
LCD screen the particle distribution curves of WBC, RBC, and platelets, along with 
data of 18 parameters, 
KX-21 performs speedy and accurate analysis of 18 parameters in blood and 
detects the abnormal   samples. Analysis data allows detecting those samples which 
are outside the tolerance   and need further analysis. 
The KX-21 uses three detector blocks and 2 kinds of reagents for blood 
analysis.  WBC detector block measures the WBC count using the DC detection 
method. RBC detector block measures the RBC count and platelets   also using the 
DC detection method. 
Hemoglobin concentration is measured by the   HGB detector block using the 
non  cyanide  hemoglobin method. 
 
 ANALYSIS PARAMETERS: 
 
The following parameters can be analysed by the instrument. 
1) Whole WBC count in 1 µL of whole blood 
2) LYM%  
Ratio (%) of lymphocytes (small cells) to whole WBC 
3) MXD%  
Ratio (%) of the summation of basophils, eosinophils and monocytes (middle cells) to 
whole WBC 
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4) NEUT% 
Ratio (%) of neutrophils (large cells) to whole WBC 
5) LYM#  
Absolute count of lymphocytes (small cells) in 1 µL of whole blood 
6) MXD#  
Absolute count of the basophils, eosinophils and monocytes (middle cells) in 1 µL of 
whole blood. 
7) NEUT# 
Absolute neutrophil count in 1 µL of whole blood 
8) RBC   
RBC count in 1 µL of whole blood 
9) HGB (Hemoglobin) 
Volume (gram) of hemoglobin in 1 dL of whole blood 
10) HCT (Hematocrit value) 
Ratio (%) of whole RBC volume in whole blood 
11) MCV (Mean RBC volume) 
Mean RBC volume (fL) in whole blood, calculated by Hct/RBC. 
12) MCH (Mean RBC hemoglobin) 
Mean hemoglobin volume (pg) per RBC, which is calculated by Hb/RBC. 
13) MCHC (Mean RBC hemoglobin concentration) 
Mean hemoglobin concentration (g/dL), which is calculated by Hb/Hct. 
14) RDW-CV (RBC distribution width in CV) 
RBC distribution width (%) calculated from the points defining 68.26% of the entire 
area from the peak of the RBC particle distribution curve. 
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15) RDW-SD (RBC distribution width - SD) 
The distribution width (fL) at the height of 20% from the bottom when the peak RBC 
particle distribution curve is taken as 100%. 
16) PLT (Platelet) 
Platelet count in 1 µL of whole blood 
17) PDW (Platelet distribution width) 
The distribution width (fL) at the height of 20% from the bottom with the peak of 
Platelet particle distribution curve taken as 100%. 
18) MPV (Mean platelet volume) 
Mean volume of platelet (fL) 
19) P-LCR (Large platelet ratio)  
Analysis principle: 
WBC: DC detection method. 
RBC: DC detection method. 
HGB: Non-cyanide hemoglobin analysis method. 
Whole blood mode: 
Blood in the sample container is aspirated as a whole without any dilution for 
analysis. 
Prediluted mode: 
Dilution of blood sample (1:26 ratio) is done in the blood obtained from the ear lobe 
or finger prick before analysis is used.  
Accuracy: 
1) Whole blood mode: 
WBC: ±3% or ±0.2 × 103/µL or less 
RBC: ±2% or ±0.03 × 106/µL or less 
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PLT: ±5% or ±10 × 103/µL or less 
2) Pre-diluted mode: 
WBC: ±5% or ±0.3 × 103/µL or less 
RBC: ±3% or ±0.05 × 106/µL or less 
PLT: ±8% or ±15 × 103/µL or less 
MCV and MCH obtained from the analyser enables classification of anemia.The red 
cell histogram shows the height at which RDW can be measured (20%).The red cell 
distrubution width RDW, is obtained from the red blood cell histogram. The RDW 
refers to anisocytosis which inturn refers to red cell size variation. In a normal 
patient,the histogram is virtually symmetrical. RDW can be expressed  as co efficient 
of variation by the following formula. 
                         RDW(CV) =  1SD/MCV x 100. 
RDW may be normal in spite of markedly increased MCV  value. In normal 
individuals it ranges from 11.5% to 14.5% but it may vary as a function of the model 
of the electronic counter used. Normal values for infants and children appear to range 
from 1.5% to 15%. 
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CLASSIFICATION OF ANEMIA BASED ON MICROCYTOSIS AND 
DISTRIBUTION WIDTH: (7)(21) 
MCV  RDW NORMAL  RDW HIGH 
Microcytosis (MCV<80 fl) Thalassemia trait, ACD, 
hemoglobinopathies  
Iron deficiency HBH disease, 
ACD, thalassemia trait, 
fragmentation syndromes. 
Normocytosis (80-100fl) ACD,hereditary 
spherocytosis, 
hemoglobinopathies, 
acute bleeding 
Partially treated iron or 
vitamin deficiency, sickle cell 
disease. 
Macrocytosis (MCV>100 fl) Aplastic anemia, 
myelodysplasias 
B12  or folate deficiency, 
AHA,cold agglutinin disease, 
myelodysplasias, liver  and 
thyroid disease, alcoholism. 
 
The degree of marrow response aids in classifying anemias as: 
1.Hyperproliferative anemias. 
2.Normoproliferative anemias. 
3.Hypoproliferative anemias. 
Above approach is helpful in understanding the pathogenetic process. In 
hypoproliferative anemia,bone marrow is unable to respond to anemia with 
reticulocytosis. In normo or hyper proliferative anemia the marrow is able to respond 
by increased  red cell production. 
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CAUSES OF MICROCYTIC ANEMIA: (2) 
1.Iron deficiency anemia. 
2.Anemia of chronic disease 
3 thalassemias. 
4.Lead poisoning. 
5. Sideroblastic anemia 
Other less common causes are lead toxicity and other hemoglobinopathies. 
Traditionally microcytic anemias are classified on the basis of MCV <80 
fl.The RDW is useful in distinguishing thalassemia from iron deficiency in that in 
thalassemias the RDW is lower and the red cell count is higher where as in iron 
deficiency the RDW is higher than normal compared to the degree of anemia.In 
anemia of chronic disease values are extremely variable with  normocytic as well as  
microcytic(particularly in patients with renal disease). serum iron profile can be used 
to differentiate  iron deficiency anemia and anemia of chronic disease  without a bone 
marrow examination. 
EVALUATION OF PERIPHERAL BLOOD SMEAR:  (19) 
Peripheral blood film examination is the single most useful procedure in the 
initial evaluation of anemic patient.  
The most common reasons for a blood film to be performed for a complete 
blood count (CBC) are: (19) 
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1.Quantitative abnormalities: 
When a measured parameter of the CBC falls outside the defined range, a 
blood film is made.The  accepted ranges of various CBC parameters are published by 
the International society for Laboratory Hematology and the Clinical and Laboratory 
Standards Institute).Each institution must adjust these  ranges to fit their own patient 
requirements. 
2.Qualitative abnormalities: 
A blood film is made when morphologic features of certain cells are detected 
and flagged as abnormal by the automated hemocytometer. 
3.Delta check: 
In this case,a number of CBC data points are stored in a data base on an 
individual patient from that patient’s previous CBC samples.Knowing this 
individual’s historical trends,if a quantitative abnormality occurs on a current CBC 
sample in a specific parameter,but the quantitative abnormality is not past the preset 
limits to trigger a blood film,still a blood film is made if the change is significant 
enough compared with the known historical trend of that individual patient. 
4.Request by the clinician: 
A CBC may be with in the limits,but the clinician still requests a blood film 
relevant to the case to look for any abnormalities. 
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BLOOD SAMPLE COLLECTION: 
CBC samples are drawn in lavender tubes containing K2 ethylene diamine 
tetraacetic acid (EDTA). This allows the blood sample to remain in a liquid state for 
analysis by a hemocytometer and for a blood film to be done.compared to K2 
EDTA,the morphology of samples anticoagulated with citrated and heparinized tubes 
is suboptimal. 
SLIDE PREPARATION: 
Blood films must be made within 12 hours of collection of K2 EDTA sample 
lest significant artifacts affect the quality of sample.A proper spreading of the film is 
essential.The slide must be 75 x 25 mm with 1 mm thickness.(44) One end of the slide 
must be frosted, although it is expensive, to facilitate labelling.  Ideally, a large area 
of cells 1 cell thick should be obtained. A poorly spread blood film will obscure basic 
morphology of the cells. Accurate assessment will then be difficult. Manual making 
depends on the skill and experience of the operator. For anemic blood the angle of 
spread must be wider and for polycythemic blood it must be wider. 
The blood film slide must be fixed immediately and not left unfixed for more 
than a few hours which allows preservation of good morphology and prevents the 
transmission of infectious diseases to the personnel in contact with the slide. Delayed 
fixations introduces morphological artifacts. Fixation is done with methanol. A 
miniscule amount of water in methanol induces hydration artifacts. 
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STAINING OF THE SLIDE: 
The various cellular structures are differentiated by staining the slide. This 
contrasting is the ability to visually distinguish one structure from another. Various 
Romanowsky stains are in use such as Giemsa,May Grunwald,Wright’s  but all these 
a combination of azure B,a cationic dye that stains nucleic acids bue and eosin, an 
anionic dye which stains hemoglobin and eosinophil granles red/orange. 
Various determinants of the staining quality are the azure B:eosin ratio,the pH 
of the buffer, contaminants,timing of the staining,age of the staining etc. 
Initial evaluation must be done with low power to determine the adequacy of 
cell distribution and staining.A poor blood film preparation includes loss of central 
pallor in RBC’s,polygonal shapes and artifactual spherocytes which show no variation 
in central pallor and are larger than normal red cells. 
Subsequent examination must be done first under high power and then oil 
immersion. Grading  should be done for size,staining intensity,variation in colour and 
abnormalities in shape.(1). 
A cover slip can be mounted either temporarily with oil or permanently with 
mountant that is miscible with xylene. It is beneficial as it allows storage of the slide  
without dust and scratch damage. The mountant must be neutral and the slide must be 
stored in the dark. 
The CBC report must be reviewed to assess the indexes reported and to look 
for any flags or concerns raised by the hemocytometer. Correlation between the 
morphologic features and the reported values can be done. 
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The  blood film must be reviewed before the clinical history is seen in order to 
objectively comment on the changes seen without being biased by the clinical 
suspicion. Later reviewing the clinical history helps the reviewer to look for a low 
level change relevant to the case. 
IDENTIFYING INFORMATION : (19) 
A unique laboratory number or the patient’s hospital number is an essential 
information to avoid jumbling of data. 
MICROSCOPIC ASSESSMENT OF THE BLOOD FILM: 
INITIAL SCREEN: 
Initially low power view is used to scan the film to look for very high or low 
cell counts,malignant cells,dual population of red blood cells etc. Both the head and 
tail end are not suitable for routine examination. The zone of morphology is the best 
area for  assessment.(19). as in this area the red cells do not show overlap and the 
central pallor is clearly visible.   
ASSESSMENT OF THE RED BLOOD CELLS: 
1.Arrangement:  
Abnormalities include rouleaux,agglutination or ball like formations. 
2. Size: 
Red blood cells are roughly 7.5 µm in diameter. The size of  a mature small 
lymphocyte is used to assess the size of  a normal red blood cell. Larger cells are 
called macrocytic and smaller cells microcytic. In general, hemocytometer indexes are 
more accurate. Sometimes,however the MCH/MCV indexes may not recognize a dual 
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population of red cells seen in partially treated  or transfused iron 
deficiency,sideroblastic anemias and combined B12 and iron deficiency. 
3. Chromaisia: 
Chromaisia refers to  the central pallor in the red blood cells. The related index 
is the MCHC(mean corpuscular hemoglobin concentration). Normal red cell has a 
central pallor approximately 1/3 to ½ of the red blood cell diameter. Hypochromasia 
indicates increased central pallor as seen in iron deficient and thalassemic states. The 
border between the stained area of the red cell and central pallor area must 
demonstrate a gradual progression. A punched out artifact may be seen in hydration 
artifact(punched out artifact). Hyperchromasia is seen spherocytosis,irregularly 
contracted red cells or some macrocytes. 
4.Colour: 
The eosin component of the Romanowsky stain imparts a pink colour to the 
normal red cell.polychromasia refers to the bluish/purplish/grayish colour of the red 
cells with increased amount of reticulin. They are called reticulocytes. To accurately 
quantitate reticulocytes,a reticulocyte count performed either by flow cytometric or by 
manual staining technique is necessary. 
5.Shape: 
Normal red cells have a round and oval shape. There are many variations in 
shape and have clinical relevance to underlying medical process. Various 
terminologies used to describe red cells in this context include: elliptocytes, 
ovalocytes, tear drop cells,spherocytes,acanthocytes,echinocytes,blister cells,bite 
cells,target cells. Red cell fragments are smaller cells without central pallor. They 
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have sharp angulated edges and have variable sizes.eg.comet cells,triangular 
cell,helmet cell and schistocytes. 
6.Inclusion bodies: 
Howell jolly bodies,pappenheimer bodies and  basophilic stippling. Nucleated 
red cells have larger,round pyknotic dark purplish nuclei which appear as inclusion. 
Red blood cell inclusion in malaria may show thin bluish rings with 1 or 2 small red 
nuclei. 
GRADING OF RED BLOOD CELL MORPHOLOGIC 
ABNORMALITIES:(3,19) 
A four point grading scale from 1+ to 4+ tied to  a percentage of red cell 
abnormality.International Society for Laboratory Hemtology guidelines suggest 
changes greater than or equal to 2+ are clinically relevant. Gene Gulati blood cell 
morphology grading guide which was published in 2009 is an useful guide for 
morphologic grading.  
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The differentiation between thalassemia especially heterozygous thalassemia 
from other causes of microcytic hypochromic anemia like iron deficiency anemia  is 
so important in a therapeutic point of view to avoid iron overload. A mild 
erythrocytosis (high RBC count) and marked microcytosis(low MCV) are 
characteristic of thalassemia trait. The RBC count is usually decreased in patients 
with iron deficiency and the MCV may be normal or decreased depending on whether 
the iron deficiency is acute or chronic. Several formulas have been developed to help 
define the 2 disordes.None are infallible but all can be useful. The cell count based 
indices especially the Mentzer index  are easily available and reliable methods to 
detect β-TT from iron deficiency anemia. 
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IRON DEFICIENCY ANEMIA:( 1,2) 
EPIDEMIOLOGY OF IRON DEFICIENCY IN CHILDREN:(8) 
World wide, iron deficiency and iron deficiency anemia affect a large 
population of people.The Fourth National Health and Nutritional Examination Survey  
(NHANES 1V) reports that iron deficiency without anemia affects 7% of toddlers 
aged 1 to 2 years,9% of adolescent girls (Looker, 2002 ) 
PHYSIOLOGIC CHEMISTRY OF IRON: 
The ability of iron to exist in 2 stable oxidation states: Fe 2+  or Fe 3+ is the 
key to its biological utility. Under physiological conditions,iron must be complexed to 
iron binding agents termed chelators.eg.transferrin in plasma. This is crucial to 
acquisition of iron from the environment  and to it’s transport and storage  with in the 
body. 
IRON PROTEIN COMPLEXES: 
Heme is an iron protoporphyrin complex IX is stable and the functional 
properties of heme is determined by the nature of the associated protein or ligands.  In 
hemoglobin,the globin histidine residue donates fifth electron and the sixth comes 
from the molecular oxygen. This configuration enables hemoglobin to transport 
oxygen safely throughout the body. 
IRON ACQUISTION AND DISTRIBUTION: (1,20,21) 
The total body iron content of a normal individual varies from 3 to 5 g in the 
adult.in the new born infant it is 0.5g. An average of 0.8 mg of iron must be absorbed 
each day during the first 15 year of life.More over loss of iron from shedding of 
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mucosal cells is to be compensated by intake of further smaller amount. Absorption of 
dietary iron is assumed to be about 10%. For optimal nutrition, diet containing 8-10 
mg of iron daily is necessary.It varies depending on the sex and weight of the 
individual. Iron increases roughly in proportion to body weight. 
IRON ABSORPTION: 
Hemoglobin iron is approximately 60-70 % of total body iron.Break down of  
this hemoglobin releases iron into  the circulation where it is bound to transferrin, iron 
binding protein.This is reutilised by the marrow erythroblasts for hemoglobin 
synthesis. 
Tissue iron or storage iron: It is equally divided between the 
reticuloendothelial cells like spleen,liver and bone marrow and hepatic parenchymal 
cells and skeletal muscle. 
FERRITIN:   
It is the predominant form in the hepatocytes where as hemosiderin is mainly 
seen in reticuloendothelial cells. Although normally not visible microscopically it is 
seen as bluish granules in tissues stained by prussian blue reaction. Ferritin is made of 
apoferritin and trivalent iron. Iso ferritins are isomers of ferritins with varying 
proportions of acidic and basic subunits. Heart and red cell ferritin contain acidic(H 
subunit). Liver,spleen and serum ferritin are L-subunit rich(33) 
HEMOSIDERIN: 
This insoluble form of storage iron represents aging of ferritin molecule  with 
partial denaturation of  apoferritin and increase in iron content. In unstained tissues it 
appears as golden yellow granules and as blue granules in potassim ferrocyanide 
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method. Inspection of amount of hemosiderin in bone marrow is an important method 
of assessing body iron stores. 
Plasma or transport iron: 
Transferrin ,a β-globulin  of molecular weight 88,000 synthesised in liver is 
the major transport protein which binds one or two atoms of ferric iron. Not only it 
carries iron from alimentary tract to tissue stores but also to erythroblasts. Transferrin 
receptors are  found in reticulocytes and erythroblasts to which transferrin is bound 
and iron is released into the cells. 
Serum transferrin is present in a concentration which enables it to combine 
with 44-80 μ mol of iron per litre. This is called iron binding capacity of the serum. 
Serum iron is normal subjects is about 20 μmol/l.The percentage of total iron binding 
protein to which iron is attached is called percentage saturation of the iron binding 
protein. Serum iron divided by total iron binding capacity which is expressed as a 
percentage gives percentage saturation. Normal value is about 33 percent that is about 
one third saturation. 
An immunoradiometric assay for measuring serum ferritin concentration was 
established by Addison et al (1972)(34). In normal individuals serum ferritin is stable 
and its concentration is related to body iron stores. It is also age and sex dependent. 
Levels in children are high at birth but rapidly fall and are low from 6 months to 15 
years of age. In iron deficiency concentrations are less than 12 μg/l and is diagnostic 
of iron deficiency. 
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Methods for assessing iron stores: (Brittenham et al(1981) and  Jacob & worwood 
(1984)(35,36) 
1.quantitative phlebotomy. 
2.liver biopsy. 
3.bone marrow aspiration and biopsy. 
4.urinary excretion of iron aster infusion of chelating agent serum iron,TIBC and 
percentage iron saturation. 
5.erythrocyte protoporphyrin. 
6.serum and red cell ferritin. 
7.dual energy computed tomography. 
8.magnetic susceptibility. 
IRON ABSORPTION: 
Absorption occurs predominantly in the proximal duodenum as the pH and 
redox potential are suitable at this site.The first part of the duodenum shows highest 
expression of the key proteins involved in the iron absorption. Active erythropoiesis 
and iron deficiency upregulates iron absorption and vice versa.  The ferrous iron is 
rapidly converted to the insouble ferric form at physiological pH. The pH in the 
duodenum is lowered by the acid produced in the stomach thereby enhancing the 
solubility and uptake of iron. Heme iron is absorbed separately from  inorganic iron 
also more efficiently thus making meat, an excellent source of iron.  The dietary 
factors which influence iron absorption are vitamin c( ascorbate ) and citrate which 
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increase iron intake by acting as weak chelators that increase the solubility of iron in 
the duodenum. Plant phytates, tannins inhibit iron absorption.  
Of the various pathways the well characterised pathway is divalent metal 
transporter  DMT-1 pathway(Conrad and Umbreit 2002,2005)(37). Separate pathways 
exist for the absorption of heme and non heme iron. 
Mucosal uptake: 
DMT -1 otherwise known as Nramp 2 or DCT -1 transports all divalent metals 
including ferrous but not ferric iron in the mucosal iron. Duodenal cytochrome b 
reductase on the enterocyte brush border reduces ferric to ferrous iron and makes it a 
substrate for transport by DMT-1. 
Mobilferrin-integrin –paraferritin pathway  transports ferric iron unreduced. 
Iron transfer  from mucosal cell to the lamina propria: 
In the mucosal cell iron is deposited as ferritin and  if iron stores are adequate, 
the worn out mucosal cells are shed after 3 to 4 days. The proteins involved in the 
transport from the basolateral portion of the mucosal cell to transferrin in the plasma 
are ferroportin or MTP-1 and hephaestin,an iron oxidase(McKie  et al 2000 and Aisen 
et al 2000)(38,39). Hephaestin is a multicopper enzyme that oxidises ferrous to ferric 
iron for incorporation into transferrin that binds only the ferric form. 
The amount of storage iron in the body and the overall rate of erythropoiesis 
decide the rate of iron absorption.Hepcidin, a negative iron metabolism regulatory 
hormone is liver derived plasma peptide(Leong & Lonnerdal 2004)(40). Intestinal iron 
absorption varies inversely with liver hepcidin expression. Iron uptake in duodenum 
and iron release from macrophages is inhibited by hepcidin. 
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IRON CYCLE: 
After absorption, iron is bound to transferrin and it is moved to erythroblasts 
of the marrow. In the marrow, iron is released from the transferrin and incorporated 
into hemoglobin. The mature erythrocytes are then released in to the circulation. After 
120 days, the aged erythrocytes are phagocytosed by the resident macrophages in the 
reticulo-endothelial system where the iron is extracted fron the hemoglobin and 
returned to plasma. Here it binds  to transferrin again completing the cycle. With each 
cycle,a small proportion of iron is transferred to storage sites and stored as 
hemosiderin or ferritin. 
INTRACELLULAR IRON TRANSPORT: 
The greatest iron content of the body is found in the erythroid precursor cells 
making about 60 to 80% of the total body iron. Approximaely 0.1 % of total body iron 
circulates in the plasma as an exchangeable pool. The function of transferrin is three 
fold : 
1. Iron is rendered soluble under physiologic conditions. 
2.Prevention of iron mediated free radical toxicity. 
3.Transport of iron into the cells. 
Thus the most important physiologic transporter of iron into the cells is 
transferrin to most parts of the body. The liver is the major site of synthesis and 
secretion of transferrin. Other sites include sertoli cells of testiss, oligodendrocytes of 
the central nervous system, lymphocytes , muscle cells  and  mammary cells .As 
serum transferrin cannot cross the blood brain barrier, some amount of local synthesis 
in these tissues provides transferrin to these organs for iron transport. 
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The sum of all iron binding sites on transferrin constitutes the total iron –
binding capacity(TIBC) of plasma. As each transferrin molecule can bind two iron 
atoms, the TIBC is twice the concentration of transferrin on a molar basis. Normally 
only one third of transferrin is filled with iron. 
IRON BALANCE; 
Since 0.5 to 1mg of iron is lost every day to maintain a normal iron balance 1 
mg of iron must be absorbed from the diet every day. 80% of iron present in a new 
born infant is accreted during the third trimester of pregnancy. So premature infants 
have deficient total body iron.(Rober D.Baker and Frank R.Greer etal).The Institute of 
medicine(IOM) suggests for infants from 7 to 12 months of age, the recommended 
dietary allowance is 11 mg/day. For toddler’s 1-3 years of age,it is 7 mg/day. 
ETIOLOGY OF IRON DEFICIENCY: 
The interaction between iron intake, physiological iron requirements and the 
potential for blood loss determines the development of iron deficiency. 
Inadequate iron intake: 
Dietary sources: 
Heme iron derieved from the animal tissues is more readily absorbed than non 
heme iron as the uptake is independent of gastric pH. In population which is 
dependent on vegetarian diets iron deficiency is thus the most common nutritional 
anemia. This is compounded by the chronic blood loss from parasitic infestations and 
malaria. 
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Consumption of cow’s milk leads to iron deficiency through several mechanisms. 
1.Low bioavailability of  iron in  cow’s milk than human milk. 
2.Replacement of iron –rich foods by cow’s milk. 
3.Cow’s milk contains calcium and caesin which interferes with iron absorption and 
low grade chronic hemorrhage  caused by irritation of the lining of GI tract by cow’s 
milk proteins. 
4.cow’s milk induced gastrointestinal bleeding.(27) 
Poor bioavailability: 
As iron is insoluble in aqueous solution, gastric acidity is required for 
absorption.plant sources have iron which has  low solubility and powerful iron 
chelators that bind the iron molecule. 
IRON DEFICIENCY ANEMIA: 
Iron is the most common single nutrient deficiency among children in the 
developing world.Iron deficiency anemia is the most common cause of anemia in 
children. The more common iron deficiency without anemia is also important in that it 
adversely affects neurodevelopment and behaviour.(Robert D Baker et al 2010). Most 
vulnerable are those between the ages 6 and 24 months of age. 
Iron deficiency may cause skin,mucosal and gastrointestinal abnormalities,low 
weight for age,reduced capacity for work and reduced immune response. It also 
compromises physical,motor,psychological,behavioural,,cognitive and language 
development. (Maria Hadler and Sigulem 2002). There is a well established 
association between iron deficiency anemia and impaired neurocognitive function 
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which is independent of psychosocial  and environmental factors (oski 1979)( 8). Also 
iron deficiency without anemia was also found to result in impaired neurocognitive 
function (Akman et al,2004)  
PATHOGENESIS OF IRON DEFICIENCY ANEMIA: (6) 
In anemia of iron deficiency, the following pathogenetic factors are described 
1.As a consequence of reduced iron supply,hemoglobin synthesis is impaired. 
2.Generalised defect in cellular proliferation. 
3.Survival of erythroid precursors and erythrocytes is reduced when the anemia is 
severe. 
As the transferrin saturation falls below 15%, the iron supply to bone marrow 
becomes inadequate to meet the requirements of hemoglobin production.  Free 
erythrocyte protoporphyrin (FEP) levels are elevated secondary to imbalance in the 
protoporphyrin : iron ratio. 
The cellular proliferation is restricted in iron deficiency inspite of relative 
erythroid hyperplasia because the degree of hyperplasia is low for the degree for the 
anemia. “Ineffective erythropoiesis” is also seen in iron deficiency resulting in rapid 
destruction of defective  immature erythroid cells . 
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STAGES OF IRON DEFICIENCY: (1,2,17,20,) 
PRELATENT: 
 Reduction in iron stores without reduced serum iron levels. 
 Detected by a low serum ferritin measurement. 
 Hb normal, MCV normal,Transferrin saturation normal,serum ferritin 
decreased,marrow iron decreased. 
LATENT: 
 Reduction in serum iron concentration and increase in iron binding capacity. 
 blood hemoglobin levels are normal. 
 Hb normal,MCV normal,TIBC increased,serum ferritin decreased,transferrin 
saturation decreased,marrow iron absent. 
IRON DEFICIENCY ANEMIA: 
 Hemoglobin levels fall below the lower limit of normal. 
 Hb decreased,MCV decreased,TIBC increased,transferrin saturation 
decreased,marrow iron absent. 
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 Stage 1(prelatent) Stage 2(latent) Stage 3(anemia) 
Bone marrow iron Reduced Absent Absent 
Serum ferritin Reduced <12μg/l <12μg/l 
Transferrin 
saturation 
Normal <16% <16% 
FEP,Zinc 
protoporphyrin 
Normal Increased Increased 
Serum transferrin 
receptor 
Normal Increased Increased 
Reticulocyte Hb 
content 
Normal Decreased Decreased 
Hemoglobin Normal Normal Reduced 
Mean corpuscular 
volume 
Normal Normal Reduced 
Symptoms Fatigue and 
malaise 
 Pallor,pica and 
epithelial changes. 
 
CAUSES OF IRON DEFICIENCY ANEMIA: 
In children increased physiological demand during the period of growth is the 
important cause  due to progressive increase in number of red cells and also the 
amount of hemoglobin. 
Nutritional deficiency due to inadequate diet is another important factor in 
infants and young children. 
Tropical sprue and celiac disease in children may also be responsible for long 
standing impairment of iron absorption as does congenital abnormalities of 
gastrointestinal tract. 
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Maternal iron deficiency, multiple pregnancy ,GI bleeding,consumption of 
large quantities of cow’s milk are other causes. 
CLINICAL FEATURES: 
In infants and young children pallor,irritability,listlessness and anorexia are 
very prominent features.pallor can be appreciated in the conjunctiva,gums and palm 
creases. In dark pigmented children nailbeds are ideal sites. 
Growth impairment occurs in infancy which cannot recover to normal levels 
even with iron therapy.Dopamine and serotonin receptor levels in the central nervous 
system are reduced permanently thus affecting the neurological development. 
Reduced myelination of spinal cord is also seen.Growth hormone levels are related to 
serum transferrin levels affecting height and weight. Delayed cognitive development 
and neuropsychological effects are seen in iron deficiency without anemia(30,3132) 
PICA: 
Craving to eat unusual substances like dirt,clay,ice(pagophagia),laundry 
starch,salt,cardboard, or hair is a classic manifestation of iron deficiency and is 
usually cured by iron administration with in 1-14 days of iron administration 
(Callinan & Hare 1988). 
IMMUNITY AND INFECTION: 
In iron deficiency, the lymphocyte mediated immunity is defective.  
Moreover, bacterial killing is also impaired.(Brock and Mullero 2000). 
PHYSICAL FINDINGS: 
       Many children are asympomatic and mostly detected by screening programmes. 
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LABORATORY FINDINGS : 
Initially the tissue iron stores represented by marrow hemosiderin disappear. 
In the absence of inflammatory disease,serum ferritin provides relatively accurate 
estimate of body iron stores.Maria  Hadler and Dirce et al suggest that serum ferritin 
is increased by two to four times as ferritin is a positive reactant in the acute phase 
(17). So ,measurement of C-Reactive protein (CRP)  can be done to rule out infections 
and inflammations. A low serum ferritin is very specific and early indicator of iron 
deficiency.(1).  In the presence of infectious process, serum ferritin level increases, 
but less than 50 μg. / litre.  Serum ferritin is a most useful of all the serum tests.  Low 
value invariably signifies iron deficiency.  This test lacks sensitivity. 
SERUM IRON :  Decreased. 
TIBC : Increased 
PERCENTAGE SATURATION OF TRANSFERRIN : 
Transferrin saturation= serum ironx100/TIBC. Normal 20 to 45% .In both 
children and adults value <5 % is diagnostic of iron deficiency(11).values <16%  is 
suggestive of iron deficiency. 
FREE ERYTHROCYTE PROTOPORPHYRIN:(FEP)  
They increase when the iron availability becomes rate limiting for hemoglobin 
synthesis. 
PERIPHERAL BLOOD FILM: 
Anisocytosis is an important early sign in iron deficiency.The chief finding  is 
hypochromia(increase in the central area of pallor more than 2/3 than normal).The 
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more severe the anemia,the more severe the hypochromia with greater percentage of 
erythrocytes affected.Microcytosis and poikilocytosis are also seen. Pencil shaped 
elongated elliptical forms are characteristic of iron deficiency.(6) 
RED CELL INDICES: 
1.Red cell distribution width (RDW)(14,11,20): 
Mean cell volume (MCV) and reticulocyte count(Demoyer et al 1989) are the 
two traditional principal criteria for the initial classification of anemic 
disorders.Anisocytosis as the coefficient of variation of red blood cell size was first 
quantified by Price jones(Judish et al 1966).More recently, the use of an analog 
computation techique with the new automated blood cell analyser is used to derieve 
RDW.(Bessman et al 1983).RDW is elevated in iron deficiency. RDW is the 
equivalent of anisocytosis observed in the peripheral smear(DeMoeyer et al 
1989).Values greater than 15% proved highly sensitive(71 to 100 %) but non 
specific(50 % ) for iron deficiency.(11). It is the standard deviation of the erythrocyte 
cell size divided  by the average erythrocyte cell size (MCV) and provides the 
percentage of erythrocytes outside the reference range.Visvanath et al 2001 and 
England et al 1976 have showed RDW was more sensitive in detecting iron 
deficiency anemia to the extent of 100% in mild degrees of anemia thus aiding the 
early diagnosis of iron deficiency anemia.Mc Cluer et al 1985 have also concluded in 
their study that RDW was 100% sensitive and was useful in early detection of early 
iron deficiency.Bessman et al 1983 ,Patton et al 1991 have showed that the early 
hematological manifestation in iron deficiency anemia.RDW is very useful in 
distinguishing from other causes of microcytic hypochromic anemias. 
MCH and MCHC are reduced in long standing  or severe disease.(6). 
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Other findings : 
White blood cell counts are normal.platelets may show thrombocytosis due to 
increased erythropoeitin which shows homology with thrombopoietin. 
BONE MARROW(6,20) 
In iron deficient subjects, bone marrow iron is reduced or absent.  The 
characteristic finding is the decrease or absence of stainable iron in bone marrow 
macrophages.(20).In bone marrow aspirates ,hemosiderin is seen as golden yellow 
refractile granules.When stained by prussian blue hemosiderin turns blue and this is 
used to grade the marrow. 
GRADE CRITERIA 
0 No iron granules observed. 
1+ Small granules seen with oil immersion 
2+ Few small granules with low power lens 
3+ Numerous small granules in marrow 
particles. 
4+ Large granules in small clumps. 
5+ Dense large clumps  of granules. 
6+ Very large deposits obscuring marrow 
details. 
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THALASSEMIAS: (20,21) 
Thalassemias are inherited genetic disorders in globin chain production.β-
Thalassemias are characterised by complete absence of  β-globin chain (β 0 
thalassemia) or  a partial reduction (β + thalassemia).α thalassemias are characterised 
by absent or partially reduced α globin chain production. The quantity of globin gene 
production is the  primary pathology in thalassemia. 
Originally thalassemias were described in Italians,Greeks and other people of 
mediterranean origin.But now it is seen in the Middle east,India,Southeast Asia and 
Blacks.Colah et al 2011 have reported that nearly 7500 to 12000 β thalassemia major 
babies are born in India each year. 
HEMOGLOBIN TYPES:(22) 
Hemoglobin A(Hb-A): 
This comprises of 97 % of hemoglobin of adult red cells.consists of 2 α and 2 
β chains with the structural formula α2β2.The α chain has 141 amino acids and the β 
chain has 146 amino acids.During the first few months of postnatal life,Hb-A almost 
completely replaces Hb-F and the adult pattern is fully established by 6 months. 
HEMOGLOBIN A2(Hb-A2): 
The structural formula is α2δ2 the delta chain containing 146 aminoacids. It is 
present in small amounts at birth and reaches adult levels or 1.5 to 3.2 percent during 
the first year of life.Elevation of Hb-A2 is a feature of some types of thalassemia.It 
may be reduced in iron deficiency. 
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HEMOGLOBIN F(Hb-F); 
The structural formula is α2γ2. Each gamma chain contains 146 
aminoacids.At term Hb-F accounts for 70-90 percent of the total hemoglobin. It then 
falls rapidly to 25 % at 1 month,and 5 % at 6 months. 
Other hemoglobins are Hb –Gower 1 &2,embryonic hemoglobins. 
PATHOPHYSIOLOGY: 
Inadequate beta globin gene production leading to decreased levels of normal 
hemoglobin Hb-A and an imbalance in alpha and beta globin chain production are the 
2 major features seen in thalassemia.In the bone marrow,thalassemic mutations 
disrupt the maturation of red cells leading to ineffective erythropoiesis.The marrow is 
hyperactive but the patient has relatively few reticulocytes and severe anemia.  
In beta thalassemias,the excess alpha chains form alpha 4 tetramers.These inclusions 
interact with the red cell membrane and shorten rred cell survival causing anemia and 
incrresed erythroid production. The gamma globin chains are produced in increased 
amounts producing elevated HbF. 
In alpha thalassemias there is excess of beta and gamma globin chains.These 
excess chains form Barts hemoglobin in fetal life and HbH (beta 4 ) at birth.These 
abnormal tetramers  cause extravascular hemolysis. 
BETA THALASSEMIA MAJOR:(12,20,21) 
The disorder is a homozygous state for the  beta thalassemia gene. Unless 
blood transfusions are given, death occurs during childhood . 
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MOLECULAR PATHOGENESIS: 
The causative mutations fall into two categories: 
 (1) β0 mutations, characterized by  absent β-globin synthesis. 
 (2) β+ mutations, characterized by reduced (but detectable) β-globin synthesis. 
More than 100 different causative mutations, mostly consisting of point mutations 
have been identified.  
• Splicing mutations. 
 These are the most common mutations which are seen in the introns leading to  β0-
thalassemia as these mutations are capable of destroying the  normal RNA splice 
junctions. Normal mRNA production is thus impaired. Mutations creating “ectopic” 
splice site within an intron leads to   β+-thalassemia . Both normal and abnormal 
splicing occurs  resulting in the production of some  normal β-globin mRNA. 
• Promoter region mutations.  
β
+
-thalassemia is mostly found in these type of mutations as transcription is 
significantly reduced with synthesis of normal globin chains.. 
• Chain terminator mutations. 
These are the most common cause of β0-thalassemia.There are two subtypes of 
mutations in this category.. The most common type creates a new stop codon within 
an exon; the second introduces small insertions or deletions that shift the mRNA 
reading frames (frameshift mutations).  Both block translation and prevent the 
synthesis of any functional β-globin.  
The IVS-1-5 mutation is the commonest mutation found in the Indian population and 
its prevalence (in homozygous state) varies from 22.8 to 81.4% in different regions of 
India, being the highest in Tamil Nadu in southeastern India. In the north-western part 
of India the 619 bp deletion mutation is the commonest beta-thalassemia mutation 
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observed in patients originating from Sindh, Gujarat or among the families migrated 
from Pakistan during partition of the country in 1947.(25) 
Impaired β-globin synthesis results in anemia by two mechanisms . 
1. The defective HbA synthesis leads to “poorly hemoglobinized” microcytic and 
hypochromic RBCs.  
2. The diminished survival of red cells and their precursors is due to insoluble 
inclusions of unpaired α chains, which precipitate within the red cell precursors.  This 
results in membrane damage and subsequent apoptosis. Those red cells that are 
released from the marrow also bear inclusions and membrane damage and are prone 
to splenic sequestration and extravascular  hemolysis. In severe β-thalassemia, it is 
estimated that 70% to 85% of red cell precursors suffer this fate, which leads to 
ineffective erythropoiesis. The first response to ineffective erythropoiesis and anaemia 
is an increased production of erythropoietin, causing a marked erythroid hyperplasia, 
which, in turn, may produce skeletal deformities, osteoporosis, and occasionally 
extramedullary masses, and contributes to splenomegaly. Untreated or undertreated 
thalassaemia major patients have retarded growth as a result of anaemia and the 
excessive metabolic burden imposed by erythroid expansion. Anaemia may produce 
cardiac enlargement and sometimes severe cardiacfailure. Ineffective erythropoiesis is 
also associated with increased iron absorption, which occurs mainly from increased 
intestinal absorption of iron caused by deficiency of hepcidin,, a 25-amino acid 
peptide produced by hepatocytes that  plays a central role in the regulation of iron 
homeostasis.(42)  
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CLINICAL FEATURES: 
Anemia: 
The earliest symptoms of the disease is usually seen in the first year of life 
when the γ- chain synthesis is not replaced by corresponding increase in the synthesis 
of β- chains. The age  at attending physician. The first sign is usually pallor with 
varying severity of splenomegaly and failure to thrive.(6) Non specific symptoms like 
anorexia and diarrhoea may also be seen. By the age of 3 years,splenomegaly 
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becomes obvious. Moderate to marked hepatomegaly is also seen.Mild jaundice is 
also seen. 
Bone deformities: 
In untransfused patients or poorly transfused patients, typical bone deformities 
are due to increased erythropoiesis and expansion of bone marrow  to about 30 times 
than normal. The skull becomes large with anterior and posterior bossing with 
increased thickness of the diploe. There is thinning of the outer and inner tables of the 
skull with the trabeculae arranged in vertical striations giving rise to “hair on end” 
appearance. Zygomatic bones become prominent with depression of base of the nose. 
Maxillary overgrowth results in severe malocclusion simulating a rodent. The 
increased erythropoiesis is noticed first in the metatarsal and metacarpal bones as 
expansion which is useful indicator to predict the time for initiation of transfusion 
therapy. The ribs are broad giving  a “rib within rib” appearance. The vertebral bodies 
give a squared out appearance. Premature fusion of  the humeral and femoral 
epiphysis leads to shortening of long bones. 
LABORATORY FINDINGS: 
Anemia is usually severe.hemoglobin levels range between 3-9 gm/dl. Marked 
anisopoikilocytosis is common. Tear drop cells are seen before splenectomy. There is 
striking hypochromia as also target cells. Nucleated RBC’s are also seen. Basophilic 
stippling is characteristically seen. 
MCV and MCH are significantly reduced. 
Polychromasia and punctate basophilia are seen to a moderate degree. 
Reticulocyte count is elevated only in patients who have undergone splenectomy. 
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Osmotic fragility test shows an increased resistance to hemolysis. 
Serum bilirubin is moderately raised. 
Serum iron and ferritin:elevated. 
Serum transferrin: fully saturated. 
Examination of siblings, parents and children is extremely important. 
BONE MARROW ASPIRATION: 
Hyperplastic erythropoiesis with increased proportion of basophilic and 
polychromatic normoblasts with smaller cytoplasm. Some normoblasts show methyl 
violet positive inclusions. Siderotic granules are seen scattered throughout cytoplasm. 
HEMOGLOBIN PATTERN: 
Predominantly Hb-F is seen with 10-98 percent of  total. Hb-A is completely 
absent with variable amounts of Hb-A 2. It may be up to 7 %. The remaining portion 
is contributed by HbA. 
ANEMIA OF CHRONIC DISEASE:(20,22) 
First described by Cartwright half century ago. This type of anemia is 
associated with number of chronic systemic diseases associated with 
infection,inflammation, or tissue break down. Infections include bronchiectasis and 
osteomyelitis. Inflammatory conditions are rheumatoid arthritis,SLE and ulcerative 
colitis. 
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PATHOGENESIS: 
Decreased RBC life span, relatively failure of bone marrow to respond to 
anemia and decreased iron availability.  Also the inflammatory cytokines chiefly IL-6 
induces the production of hepcidin which decreases intestinal iron absorption and 
blocks release of iron from macrophages. In response to inflammatory cytokines, 
increasingly IL-6,(24) the liver produces increased amounts of hepcidin. Hepcidin in 
turn causes increased internalisation of ferroportin molecules on cell membranes 
which prevents release from iron stores. Inflammatory cytokines also appear to affect 
other important elements of iron metabolism, including decreasing  ferroportin  
expression, and probably directly blunting erythropoiesis by decreasing the ability of 
the bone marrow to respond to erythropoietin. 
In addition to effects of iron sequestration, inflammatory cytokines promote 
the production of white blood cells. Bone marrow produces both white blood 
cells and red blood cells from the same precursor stem cells. Therefore, the 
upregulation of white blood cells causes fewer stem cells to differentiate into red 
blood cells. This effect may be an important additional cause for the 
decreased erythropoiesis and red blood cell production seen in anemia of 
inflammation, even when erythropoietin levels are normal, and even aside from the 
effects of hepcidin. Nonetheless, there are other mechanisms that also contribute to 
the lowering of hemoglobin levels during inflammation: (i) Inflammatory cytokines 
suppress the proliferation of erythroid precursors in the bone marrow; (ii) 
inflammatory cytokines inhibit the release of erythropoietin (EPO) from the kidney; 
and (iii) the survival of circulating red cells is shortened. 
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CLINICAL FEATURES: 
Most symptoms and signs are related to the underlying disorder with mild to 
moderate anemia. 
LABORATORY FINDINGS: 
Hemoglobin levels are 6-9gm/dl.  
Usually anemia is normochromic and normocytic with modest 
microcytic,hypochromic features. Mild anisocytosis may be seen. 
Reticulocyte counts are normal or low. 
Serum iron: decreased. 
TIBC: normal to low. 
This pattern of low serum iron and low to normal iron binding protein is a regular and 
a valuable diagnostic feature. 
Serum ferritin: elevated. 
Bone marrow: normal cellularity.Iron content may be increased. 
C-Reactive protein levels are elevated.In infants and children a level greater than 6 
mg/l  indicates infection or inflammation. This is an acute phase reactant whose 
concentration increases rapidly in infections and inflammations.(17)   Inflammation is 
the key to the diagnosis  and control of inflammation eliminates anemia.   
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SIDEROBLASTIC ANEMIAS:. 
These are acquired and hereditary disorders of heme synthesis.Impaired heme 
synthesis leads to retention of iron with in the mitochondria. Only few sideroblastic 
anemias are seen in children. 
CONGENITAL SIDEROBLASTIC ANEMIA: 
This is a rare X linked congenital disorder.autosomal dominant pattern as well 
as sporadic forms are seen. The rate limiting enzyme 5-aminolevulinic acid synthetase  
is abnormal in all cases. 
CLINICAL FEATURES: 
Only severe anemias are seen in childhood with pallor,icterus and moderate 
splenomegaly and hepatomegaly. 
LABORATORY FEATURES: 
Microcytic hypochromic peripheral smear with normal RBC”s give a 
dimorphic picture.There is an extremely high RBC distribution width(RDW). 
Serum iron: elevated. 
Transferrin saturation: increased. 
BONE MARROW: 
Ringed sideroblasts which are nucleated RBC’s with iron aggregates in 
mitochondria that have a perinuclear distrubution are seen. 
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DIFFERENTIAL DIAGNOSIS OF MICROCYTIC HYPOCHROMIC 
ANAEMIA – LABORATORY FEATURES (20) 
 
Tests Iron 
Deficiency 
ACD Thalassemia Sideroblastic 
Anaemia 
MCV Decreased 
 
Normal or 
Decreased 
   
Markedly 
Decreased 
 
Decreased 
 
RDW Increased 
 
Increased or 
Normal  
Increased 
 
Increased or 
Normal  
RBC 
Morphology  
    
Red cell count Decreased 
 
Decreased 
 
Normal Normal 
Serum Iron Decreased 
 
Decreased or 
Normal 
 
 
Increased or 
Normal 
 
Increased or 
Normal  
Tests Iron 
Deficiency 
ACD Thalassemia Sideroblastic 
Anaemia 
TIBC Increased 
 
 
Decreased 
 
Normal Normal 
Percent 
Saturation 
Decreased 
 
Decreased or 
Normal  
 
Increased or 
Normal 
 
Increased or 
Normal  
Ferritin Decreased 
 
 
Increased or 
Normal  
Normal Normal 
Serum 
Transferrin 
Receptor 
Increased 
 
Normal Increased 
 
Normal 
FEP Increased 
 
 
Increased 
 
Normal Increased 
 
Hb Electro 
Phoresis 
Normal Normal Abnormal Normal 
Marrow Iron Low or Absent 
 
Increased or 
Normal  
Normal Ring 
Sideroblasts > 
15% 
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CURRENT MODALITIES IN THE DIAGNOSIS OF MICROCYTIC 
ANAEMIA: 
Soluble transferrin receptors: (1,2,11,26) 
It is an normal proteolytic cleavage product of transferrin receptor derieved 
from erythroid precursor cells.During the early development of iron deficiency serum 
transferrin receptor levels are increased and is a sensitive response.It is not affected by 
infection or inflammation.does not vary with age ,sex or pregnancy. But in ineffective 
erythropoiesis it may be elevated.In distinguishing iron deficiency from anemia of 
inflammation this parameter is very helpful.(oliveras et al 2000,Vazquez et al 
2006).(8). TfR1 detects iron at cellular level. It is found on cell membranes. In 
deficiency states, there is upregulation of receptors  and more concentrations are 
found in the serum. The cellular transferrin receptor (TfR) molecule is a 
transmembrane protein that binds transferrin, the principal iron transport protein 
found in the blood.1,2 TfR is found in highest concentration on the surface of cells 
requiring large amounts of iron, such as hemoglobin-synthesizing cells of the 
reticuloendothelial system (ie, bone marrow, liver, and spleen)3 and the placenta.4-7 
In 1986, Kohgo et al, were the first to demonstrate the presence of a soluble form of 
TfR in human serum that was identified subsequently as a truncated form of cellular 
TfR derived from proteolytic cleavage of its extracellular segment.9-11 Moreover, 
80% of the total serum level of TfR originates from immature RBC progenitors, 
including reticulocytes, while 20% originates from nonerythroid tissues. 
CHr:(1)(2) 
Reticulocyte hemoglobin concentration(29) is available only in selected 
laboratories as it is unique to certain types of analysers. In a recent study it was found 
to have high and specificity in the detection of early iron deficiency.Both CHr and 
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TfR1 concentrations are not affected by inflammation and infection or anemia of 
chronic disease.CHr assay is currently available for use in children as it is validated 
and standard values have been determined. It provides a measure of iron available to 
cells recently released from the bone marrow. This is measured by flow cytometry 
TfR –index:  
Ratio of soluble transferrin receptor to the log of serum ferritin values >15 
suggest iron deficiency alone or  in combination with inflammatory conditions. Value 
<15 is characteristic or anemia of chronic diseases. This index is also sensitive enough 
in detecting iron deficiency.(11) 
Free erythrocyte protoporphyrin: 
This parameter is useful in microcytic anemia due to lead poisoning as  lead 
directly inhibits ferrochelatase the last enzyme in heme biosynthesis. 
Ret Y: 
 It is a sensitive indicator of early iron deficiency.(Brunagara et al). Present 
automated hematology analyser can measure  the reticulocyte size (Ret Y) values and 
correlates closely to sTfR. The sensitivity and specificity overall is highest  of  all the 
panel of tests. 
In a prospective study it was found that a cut off of 27.5 pg had 83% 
sensitivity and 72% specificity.(1). 
Hemoglobin separation to determine Hb pattern is performed in case of 
thalassemias with different methods like electrophoresis at alkaline pH,isoelectric 
focussing,high performance liquid chromatography. 
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OBSERVATION AND RESULTS 
 
The age of  50  randomly selected cases in our study ranged from 6 months to 12 
years.  The age and sex distribution of cases is shown in Diagram 1 
DIAGRAM 1 
 
 
The mean age and median age was 5.64 years. & 5 years respectively.   
Among the various clinical features, pica was noticed in 35 cases of IDA (85.3%). 
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No. of cases with mild, moderate and severe anaemia are 13, 19 & 18 respectively 
(26%, 38% & 36%).  This is shown in Diagram 2 
                                               
DIAGRAM-2 
 
 
Ninety nine percentage of cases in our study had RBC count less than 5 million.  
Only one case of Thalassemia major showed RBC count greater than 5 million. 
Various RBC parameters are shown in the Table 1 
TABLE 1 
RBC Parameters 
 IDA ACD 
RBC count (x 106 μL) 3.60 (1.6 – 4.68) 3.9 (3.35 – 5.06) 
Hemoglobin (g./dl) 7.19 (3.1 – 10.9) 8.9 (6.5 – 11.4) 
Hematocrit (%) 24.22 (9.7 – 33.2) 28.32 (22.8 – 32.8) 
MCV (fml) 67.22 (50.3 – 80) 71.2 (57.7 – 79.2) 
MCH (pg) 20.67 (11.5 – 28.6) 23.18 (15.2 – 31.3) 
MCHC (g/dl) 29.33 (19.6 – 38.7) 29.9 (26 – 34.8) 
RDW (%) 21.5 (12.7 – 34.9) 15.38 (12.3 – 22.6) 
   
26
38
36
% of cases
Mild
Moderate
Severe
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All the RBC parameters were expressed in mean with the range of values in 
parenthesis for IDA and ACD cases.  Only one case of Thalassemia major was 
reported in the present study.   
The sensitivity, specificity, positive predictive value and negative predictive value of 
RDW in the diagnosis of IDA was calculated in the following formula. 
Sensitivity = (true positive / (true positive + false negative))X100 
Specificity = (true negative / (true negative + false positive))X100 
PPV = (true positive / (true positive + false positive))X100 
NPV = (true negative / (true negative + false negative))X100 
The cut off value of RDW for diagnosis of IDA was taken as 13.4 in our study 
Test result IDA Non-IDA Total 
Positive 39 3 42 
Negative 2 6 8 
 
Sensitivity = 39/(39+2) X 100 = 95% 
Specificity = 6/(6+3) X 100 = 66% 
PPV = 39/(39+3) X 100 = 92.8% 
NPV = 6/(6+2) X 100 = 75% 
CORRELATION 
RDW Vs S.FERRITIN r = -0.04 
RDW VS TIBC r =  0.30 
RDW Vs TRANSFERRIN r  = -0.20 
RDW VS ON SATURATION r = -0.28 
RDW VS S.IRON r = -0.16 
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     The correlation co-efficient (r) between RDW Vs. Serum Ferritin, RDW Vs. 
Transferrin, RDW Vs. Percent Saturation of Iron, RDW Vs. S.Iron showed strong 
negative association, i.e, when one variable increases, other decreases. When the 
serum ferritin,  serum iron, percent saturation increases, the RDW which is a measure 
of anisocytosis returns to normal values. So this correlation was statistically 
significant. 
     In the Peripheral blood film examination, No. of smears showing pencil cells was 
16 (39%) out of 41 cases of IDA, showing that peripheral blood film was sensitive 
only when the iron deficiency is more pronounced. 
 
  
 Grading of  microcytosis
grading guide by Gene Gulati .
1+ grade 
2+ grade. 
3+ grade. 
4+ grade. 
 
In the peripheral blood film, 200 RBC’s were counted to check for microcytic and 
hypochromic cells. In o
with respect to microcytosis and hypochromia.
 
Grade 1 + 
Grade 2 + 
Grade 3 + 
Grade 4 + 
 
0
5
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35
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Grade 1 +
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  and hypochromia  was done using Blood cell morphology 
 
<25 cells/100 RBC’S 
25-50 cells/100 RBC’S.
50-75 cells/100 RBC’S
>75 cells/ RBC’S. 
ur study, out of 50 cases of anemia, following grade was seen 
 
No. of smears Percentage
13 
19 
10 
8 
Grade 2 + Grade 3 + Grade 4 +
 
 
 
26% 
38% 
20% 
16% 
 
No. of 
smears
Percentage
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The percentage of hypochromic cells according to various studies  
The sensitivity, specificity, PPV, NPV and the Youden’s index of the various Red cell 
formulas were calculated and tabulated  as follows : 
Indices Cut off values for 
IDA 
No.of cases of 
IDA correctly 
diagnosed 
(n=41) 
Percentage 
Mentzer’s >13 39 95 
Srivastava >3.8 35 85 
Shine & lal >1530 38 92.6 
Ricerca >4.4 33 80.4 
Ehsani >15 37 90.2 
RDWI >220 40 97.5 
MDHL <1.63 41 100 
MCHD <0.30 13 31.7 
Sirdah >27 41 100 
RBC count <5 41 100 
England & 
Fraser 
>0 41 100 
 
 The various Red cell formulas, in the order of percentage of IDA cases 
correctly diagnosed, were ranked as follows: 
 I. Sirdah, RBC count, E&F, MDHL    II. RDWI   
 III. Mentzer’s   IV. Shine & Lal   
 V. Ehsani     VI. Srivatsava    
 VII. Ricerca   VIII. MCHD 
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Indices Sensitivity Specificity PPV NPV Youden’s 
Mentzer’s 95.12 11.11 82.97 33.33 6.23 
Srivastava 85.36 11.11 81.39 14.28 3.52 
Shine & lal 7.31 6.66 50 13.63 -26.1 
Ricerca 8.48 77.77 94.28 46.66 58.26 
Ehsani 9.24 11.11 82.22 20 1.35 
RDWI 97.56 22.22 85.10 66.66 19.78 
MDHL 100 0 82 - 0 
MCHD 31.70 55.55 76.47 15.15 -12.73 
Sirdah 100 0 82 - 0 
RBC count 100 11.11 83.67 100 11.11 
England & Fraser 100 0 82 - 0 
 
 Highest sensitivity was ranked in the following order: 
            I. Sirdah, RBC count, E&F, MDHL    II. RDWI >  
 III. Mentzer’s   IV. Srivastava   
 V. MCHD     VI. Ehsani  
 VII. Ricerca    VIII. Shine & Lal  
 Highest specificity was ranked in the following order: 
 I. Ricerca  II. MCHD  
 Highest PPV was ranked in the following order: 
 I. Ricerca  II. RDWI 
 Highest NPV was shown by RDWI 
          Youden’s index was highest for Ricerca index.  
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TYPE OF CASE NO OF CASES 
 
PERCENTAGE 
IDA 41 
 
82 % 
ACD 8 
 
16 % 
THALASSEMIA 
MAJOR. 1 
 
2 % 
TOTAL 50 
 
100 % 
AVERAGE 16.67 
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DISCUSSION 
 
In our present study involving 50 randomly selected cases, the various red cell 
indices like hemoglobin, RBC count ,MCV, MCH and MCHC were obtained from the 
SYSMEX 3 part analyser. The Serum iron profile which comprised of serum iron, 
serum ferritin, Total iron binding capacity and percent saturation of transferring  was 
obtained from a private laboratory with specified reference values. Assuming, the  
serum iron profile to be  more helpful  as a gold standard in the differential  diagnosis 
of  microcytic hypochromic anemia, the various parameters such as RBC count, 
Hemoglobin, RDW  were correlated with  iron profile . 
In our present study,  the  predominant  age group involved was  6 months to 3 
years.(50%).In their study, Jain et al 2000(13) have reported high prevalence of anemia 
between 1 to 2 years(59.9%).In the ICMR Study 1985(13), age group most involved 
was  also between 1 to 3 years.(63%). The hospital based study in Nepal by Arnab et 
al(10) showed commonest age group between 1-6 years.(10). Roosy  Aulakh et al(14) , in 
their study reported  increased prevalence in the age group between 1-5 years. 
  
 study 
Jain et al 2000 
ICMR 1985 
Arnab et al2015 
Roosy Aulakh et al 2008
Present study 2015 
 
Our study corresponds to the other studies in terms of predominant age group 
involved.ie.more number of children with anemia are found in the age group between 
6 months to 3 years. 
In terms of predominant sex involved, present study  showed out of 50 children more 
males (32)(64%)were involved than females (18)(36%).
studies also.Sunil et al
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Table  No: 1 
Age group percentage
1-2 years 59.9% 
1-3 years 63% 
1-6 years 45% 
 1-5 years 52.3% 
6 months-3 years 50% 
 This corresponded to other 
(5) 
 found  a 50% male children involved in their study. Sant
- ICMR  1-3 
yrs
Arnab et al 
1-6 yrs
Roosy et al 
2008
Present 
study 6m-
3yrs
63%
45%
52.30%
50%
Percentage
 
 
osh 
percentage
 et al (13) and Roosy 
involvement in their studies.
Sunil et al 2014 
Santosh et al 2013 
Roosy et al 2008 
Present study 2015 
 
The mean  values of va
MCV, mean RDW  and the biochemical profile  like mean serum ferritin in our study 
were in coincidence with the other  studies like  Sazawal et al 2014
al 2013(13) . This is shown in the following 
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 Aulakh et al(14) have reported a 60% and  70% of  male 
  
Table No:2 
50% 
60% 
70% 
64%  
rious RBC  parameters like mean Hb ,mean
table: 
percentage
Roosy et al
Present 
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  MCH, mean 
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Table No:3  Comparison with Sazawal et al 
   
  
Present study Sazawal et al 
 
Parameters Iron deficient 
anemia. 
Non iron 
deficient 
anemia. 
Iron 
deficient 
anemia. 
Non iron 
deficient 
anemia. 
Mean RBC(millions) 3.6 3.9 4.2 4.4 
Mean Hb(g/dl) 7.19 8.9 8.4 10.9 
Mean MCV(fml) 67.22 71.2 69.6 78.9 
Mean MCH(Pg) 20.67 23.18 20.0 24.2 
Mean RDW(%) 21.57 15.38 19.9 16.8 
Mean Ferritin 8.24 ng/ml 233.3 ng/ml 6.2 μg/l 16.3 μg/l 
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Table No:4: Comparison with Santosh et al 
 Present study Santosh et al 
Parameters Iron 
deficient 
anemia. 
Non iron 
deficient 
anemia. 
Iron 
deficient 
anemia. 
Non iron 
deficient 
anemia. 
Mean RBC(millions) 3.6 3.9 4.01 4.4 
Mean Hb (g/dl) 7.19 8.9 9.0 10.9 
Mean MCV(fml) 67.22 71.2 70.3 78.9 
Mean MCH(Pg) 20.67 23.18 23.3 24.2 
Mean RDW(%) 21.57 15.38 16.6 16.8 
Mean Ferritin 8.24ng/ml 233.3ng/ml 6.2μg/l 16.3 μg/l 
 
These parameters are compared to show that the mean values derieved in our 
study and from the other studies were not significantly different to affect the study 
outcome. The serum ferritin value alone showed difference because the reference 
values of individual laboratories vary between each other. In our study, the 
laboratory reference value was  between 7-140 ng/ml. 
The sensitivity and specificity of Red cell distribution width (RDW) was 
compared with that of other studies. Various studies reported more than 95% to 100 
% sensitivity in the diagnosis of early iron deficiency.  In the present study, the 
sensitivity  and specificity was 95%  and  66% respectively. The following  table 
shows the comparison with other studies. 
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Study Sensitivity and 
specificity(%) 
Cut off value in % 
Santosh et al 2013 100 - 
Viswanath et al 2001 and 
England  et al 1976. 
100 - 
Mc Clure et al 1985 100 - 
Bessmann et al 1983 96 - 
Von Zeben et al 1990 94 & 59 14.5 
Flynn et al 1998 94 & 51 13.4 
Kim et al 1996 83 & 57 15 
Aulakh et al 2008 81 & 53 17.4 
Sazawal et al 2014 90.4 & 98.9 15 
Present study 2015 95 & 66 13.4 
  
From the above table it is obvious that as the cut off value is lowered from 
17.4 to 13.4, the sensitivity increases but the specificity decreases.  In the present 
study, the specificity of 66% could be attributed to the low cut off value. But in our 
country where IDA is the more prevalent microcytic hypochromic anemia, a low cut 
off value is permissible as it could pick up more cases of IDA which is advantageous 
in term of long term outcome. But the disadvantage is that when the specificity is 
lost,   more cases of anemia of chronic diseases and some cases of heterozygous α 
and β thalassemias, where RDW is normal would also be included in the list of IDA. 
So as a reasonable balance, the cut off value of RDW  would be set as >15% as in the 
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study of Sazawal et al and Kim et al(5), which would allow a good sensitivity and 
specificity. 
According to Sezawal et al(5), the expensive investigations needed for the 
diagnosis of most common microcytic anemia,IDA such as iron status markers  
necessitates the use of cost effective tools. The increase in RDW may occur even 
before the decrease in MCV. They also conclude that RDW may very well be 
employed in large sample settings as a screening tool  to identify iron deficiency 
anemia. They suggest a cut off value of RDW >15% and hemoglobin <10 g/dl. 
As seen in the observation and results, there was  a statistically significant 
negative association between RDW and serum ferritin, serum transferrin, percent 
iron saturation. 
Although the various red cell formulas are used to discriminate IDA from Beta 
thalassemia especially thalassemia trait(discriminant index),Sazawal et al(5) suggest 
that they can still be sued to predict IDA 
1. Mentzer index: 
In our study the percentage of correctly diagnosed children in the case of IDA 
was 95% which conforms to studies of Aysel et al(4)  (91%) and Ehsani et al 
(94%). The sensitivity ( 95%)  was also  in concordance with  the above studies . 
Study Sensitivity specificity 
Aysel et al 98.7% 82.3% 
Ehsani et al 95.5% 94.6% 
Present study 95.12% 11.11% 
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The high sensitivity means the index is able to predict   more IDA cases. But 
the low specificity in the present study was due to the control group of anemia cases   
used, which were mostly ACD cases. In contrast, in the above studies, β-Thalassemia 
trait cases were used  as controls, as those studies were conducted in thalassemia belts 
with high prevalence of thalassemia trait cases. The formula   uses RBC count as the 
denominator. In the study by Aysel et al, the mean RBC count was 5.6+ or -4. In our 
study the mean RBC count was 3.6 million. In thalassemia  trait  the RBC count is 
normal or even increased(20).  With the high RBC counts the Mentzer’s index would 
be less than 13 resulting in the high specificity in their study. In the present study, 
majority of ACD cases(88%) had less RBC counts that had resulted in  Mentzer’s 
index greater than 13 and  thus low specificity. More over, in the present   study, all 
the ACD cases had a higher CRP values which was predictive of anemia of chronic 
disease. 
Srivastava (1973) index: 
Here again, the formula uses  RBC  count as the denominator, but the cut off  
to diagnose IDA was greater than 3.8. So the sensitivity in their study Aysel et al 
(4)
,was about 72% and the specificity was 85%. In our study, the sensitivity and 
specificity were 85.36% and 11.11% respectively. 
The following table compares the sensitivity and specificity of the other   indices with 
the corresponding values from the other 2 studies. 
Indices Sensitivity Specificity 
Srivastava   
Present study 85.36 11.11 
Aysel et al 72 85.7 
Ehsani et al 88.5 85.7 
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Indices Sensitivity Specificity 
Shine & lal   
Present study 7.31 6.66 
Aysel et al 10.2 100 
Ehsani et al 
 
- - 
 
Indices Sensitivity Specificity 
Ricerca   
Present study 8.48 77.77 
Aysel et al 14.7 100 
Ehsani et al - - 
 
Indices Sensitivity Specificity 
Ehsani   
Present study 9.24 11.11 
Aysel et al 73.5 94.8 
Ehsani et al 90 95.5 
 
Indices Sensitivity Specificity 
RDWI   
Present study 97.56 22.22 
Aysel et al 76.4 83.1 
Ehsani et al - - 
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Indices Sensitivity Specificity 
MDHL   
Present study 100 0 
Aysel et al 58.8 76 
Ehsani et al - - 
 
Indices Sensitivity Specificity 
MCHD   
Present study 31.70 55.55 
Aysel et al 27.9 77.9 
Ehsani et al - - 
 
Indices Sensitivity Specificity 
Sirdah   
Present study 100 0 
Aysel et al 22 108 
Ehsani et al - - 
 
Indices Sensitivity Specificity 
RBC count   
Present study 100 11.11 
Aysel et al 8 96 
Ehsani et al 86.2 98.1 
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Indices Sensitivity Specificity 
England & Fraser   
Present study 100 0 
Aysel et al 52 116 
Ehsani et al 99.2 69.5 
 
In the present study, the best indices to predict IDA were in the following order: 
1. Sirdah. 
2. RBC count. 
3. E&F. 
4. Mean density of hemoglobin per liter of blood (MDHL). 
5. RDWI. 
6. Mentzer’s index. 
This is in contrast to Aysel et al who found in their study Mentzer index to be 
most reliable and Ehsani et al who found that Mentzer to be the most reliable and 
then Ehsani to be the second most sensitive index to discriminate between IDA and β 
TT. 
In the present study the indices with the highest sensitivity were   Sirdah ,RBC 
count, England and Fraser index. The following table shows comparison with other 
studies: 
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Studies Sample size Best index 
Demir et al(2002) 63 RBC Count 
Ntaios et al(2007) 493 Green & King 
Beyan et al(2007) 111 RBC count 
Urrechaga et al(2008) 2196 Green & King 
Sirdah et al(2008) 2196 Green & King 
Present study(2015) 50 Sirdah ,E & F 
RBC count. 
 
It is important to that iron deficiency anemia is treated adequately in young 
children. Often  the clinical history, diet enquiry ,physical examination of the child  
and the peripheral blood film along with the measurement of red cell indices leads to 
the correct diagnosis. In case of doubt , a therapeutic trial of iron may be given with 
dietary advice. This approach is reasonable without any harm even in case of 
infections or a thalassemia trait. The investigation of thalassemia trait may be done 
after correction of iron deficiency. If the hemoglobin concentration and red cell 
indices do not return to normal, then further investigation may be done (9). 
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CONCLUSION 
1. Microcytic  hypochromic  anemia is mostly caused by  iron deficiency, 
thalassemias, anemia of chronic disease and  very rarely  sideroblastic anemia. In the 
present study, Iron deficiency anemia and anemia of chronic disease were found 
most commonly than thalassemia or  sideroblastic anemia. 
2. The basic hematology data obtained from a automated hematology analyser such 
as MCV and MCH  are helpful in classifying anemia into microcytic  hypochromic  
or other categories. 
3. The RDW, which is a measure of anisocytosis  is an early sign of iron deficiency. 
The changes in RDW occur early than MCV changes. In the present study, the RDW 
was found to be very sensitive but less specific in the early detection of iron 
deficiency. 
4. There was also significant negative association for RDW with serum ferritin, 
serum transferrin, serum iron values which shows that with increase in the iron 
values after treatment, the RDW returns to normal. The association is therefore 
statistically significant. 
5. The various red cell formulas calculated in the present study showed that the 
indices sirdah, RDWI, England and Fraser were 100 % sensitive but less specific. 
The low specificity was attributable to the low RBC count in the present study. 
6. The C-Reactive protein was also useful in distinguishing between the iron 
deficiency and anemia of chronic disease cases in the present study. 
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7. The peripheral smear was useful only in severe cases of iron deficiency with the 
identification of   pencil cells but overall the sensitivity was very low in mild and 
moderate iron deficiency. 
8. In the present study there was only one case of thalassemia major which was 
clinically identified by the typical facies, abundance of target cells in the peripheral 
blood film and the typical hemoglobin electrophoresis pattern. 
9. Therefore in the Iron deficient anemias, the recommended cost effective strategy 
with the presently available facilities in a low resource setting would be.  
a) A low MCV and increased RDW with a cut off value of <15 in the highly 
prevalent areas to pick up more cases with increased sensitivity. 
b) The peripheral smear may be used to confirm the morphology as microcytic 
hypochromic and the presence of pencil cells in severe cases. 
c) The calculation of various red cell indices could be easily made to detect 
iron deficient anemia. 
d) Lastly a reticulocyte count could be done not only to rule out hemolysis but 
also to assess the bone marrow response after a trial of oral iron therapy after 2 
weeks. A CRP measurement may be done in all microcytic anemias to rule out  
as well as diagnose anemia of chronic disease. 
10. The strategy in case of anemia of chronic disease would be as follows: 
a) The clinical manifestations of the underlying infections and inflammatory 
conditions. In our study many children had juvenile rheumatoid arthritis and 
few were diagnosed as to have renal disease. 
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b)  Increased  Erythrocyte sedimentation Rate (ESR) and CRP values.  
c) Other investigations directed towards the diagnosis of underlying 
inflammatory condition and treatment. With treatment, a peripheral smear and 
Complete hemogram may be done to check for correction of anemia. If no 
correction of anemia is seen, only then costly investigations such as serum 
hepcidin and serum iron markers may be done. 
11.In case of thalassemias, the diagnosis and confirmation of thalassemia major 
depends heavily on costly strategies such as hemoglobin electrophoresis which is 
justifiable with the morbidity of the disease namely life long blood transfusion 
programmes. 
12. The cases of thalassemia minor or trait may be initially screened by a elevated 
RBC count and a normal RDW value along with the use of discriminant red cell 
indices but still newer cost effective strategies need to be designed.                 
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APPENDIX- 1 
TABLE 1: 
Hematological values for normal children ( expressed as mean + 2 SD or 95% 
range) 
 1 year 2-6 years 6-12 years 
Red   cell 
count(1012/l)  
4.5 + 0.6 4.6 + 0.6 4.6 + 0.6 
Hemoglobin 
concentration (g/l) 
126 + 15 125 + 15 135 + 20 
Hematocrit (Hct) 
or packed cell 
volume( PCV) (l/l) 
0.34 + 0.04  0.37 + 0.03 0.40 + 0.05 
Mean cell volume 
(MCV) (fml) 
78 + 6 81 + 6 86 + 9 
Mean cell 
hemoglobin 
(MCH) (pg) 
27 + 2 27 + 3 29 + 4 
Mean cell 
hemoglobin 
concentration 
(MCHC) (g/l) 
 340 + 20 340 +30  340 + 30 
Reticulocytes 
(109/l) 
30 -100 30 -100 30 -100 
Platelets (109/l) 200 -550 200 -490 170 -450 
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APPENDIX -2 
DEPENDENT 
 Preparation of leishman’s stain and staining method: 
1. Weigh 200 mg of the powdered dye. 
2. Transfer the content to a conical flask of 200 -250 ml capacity. 
3. Add 100 ml of methanol. 
4. Warm the mixture to 50* C for 15 min with occasional shaking. 
5. Allow the flask to cool and filter the solution. 
 
Staining method: 
1. Air dry the blood film. 
2. Flood the slide with the leishman’s stain. 
3. After 2 min, add double the volume of water and stain for 5-7 min. 
4. Wash in a stream of buffered water with pH 6.8 until  a pinkish tinge appears. 
5. Wipe the back of the slide and stand the slide upright to dry.  
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                   APPENDIX-3 
Reticulocyte  Stain and Reticulocyte count: 
New Methylene Blue is the commonly used stain for reticulocyte count . It gives 
better results than brilliant cresyl blue because it stains the reticulo filamentous 
material more deeply and more uniformly than does brilliant cresyl blue.  
1. Dissolve 1 g of New Methylene blue in 100 ml of 3 % trisodium citrate solution. 
2. Filter once the dye has been dissolved. 
 
Method: 
1.Deliver 2 to 3 drops of the dye solution into 1 75 x 10 mm plastic tube with a 
Pasteur pipette. 
2. Add 2 to 4 volumes of the patient’s EDTA anticoagulated blood to the dye solution 
and mix. 
3. Keep the mixture at 37 * C for 15 -20  min. 
4. Resuspend the red cells by gentle mixing of the solution. 
5. Make films on the glass slides in the same manner as blood film. 
6. When dry, examine the films without fixing or counter staining. 
 
Result: 
The reticulofilamentous material is stained deep blue. The non reticulated cells are 
stained in diffuse shades of pale greenish blue. 
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APPENDIX  4 
Prussian Blue stain and staining method of bone marrow aspirate: 
1.  Mix equal volumes of 20 g/l  potassium ferrocyanide and 0.2 mmol/l of Hcl. 
 
Method: 
1. Air dry film containing bone marrow aspirate. 
2. Fix with methanol for 10 -20 min. 
3. After drying, place the slides in a solution containing 10 g/l  potassium    
    ferrocyanide in 0.1 mol/l of HCl. 
4. Leave the slides in the solution for about 10 min at about 20*C. 
5. Wash well in running tap water for about 20 min. 
6. Rinse thoroughly in distilled water. 
7. Counter stain with 1g/l aqueous eosin for 10 – 15 sec. 
8.  Wash in running water and stand upright to dry. 
 
Precautions: 
1. Avoid contamination by iron present on the slides or dishes. 
2. Prepare the glass ware by soaking in 3 mol/l HCL before washing. 
3. A positive bone marrow film is stained together with the test films for quality  
    control.                 
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